Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2003
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003CN1449381A New compounds having activity of lowing blood fat and cholesterol, their preparation method and pharmaceutical compositions containing them
10/15/2003CN1124263C Stabilised monomer composition
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632951 Making N- methylpyrrolidine and analogous compounds via hydrogenation. Novel catalysts for this process, and novel conditions/yields are also described. Other process improvements may include extraction and hydrolysis steps.
10/14/2003US6632950 By reducing the corresponding 4-nitro derivative; useful as monomers for polyamides capable of binding dsDNA (double stranded DNA) and hence in nucleotide sequence recognition
10/14/2003US6632929 Avidin derivatives and uses thereof
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632833 2-(2-methylphenyl)-3,4-dihydro-2H-pyrrole derivatives
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/14/2003CA2107894C Crosstalk inhibitors and their uses
10/09/2003WO2003082928A1 Control agents for living-type free radical polymerization and methods of polymerizing
10/09/2003WO2003082826A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003WO2003082816A1 New atorvastatin salts and pharmaceutical compositions containing them
10/09/2003WO2003082815A1 Method of heightening optical purity of 1-benzyl-3-aminopyrrolidine and salt for use therein
10/09/2003WO2003082814A1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082298A1 Statin therapy for enhancing cognitive maintenance
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2003082267A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191322 Synthetic pathway from reacting chemical intermediates 4-carboxy oxazoline with a formyl amide, decarboxylation, hydroxylation, decyclization, lactamization, saponification; proteasome inhibitors, antiinflammatory, antitumor agents
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191168 Binding to nucleic acids
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191104 Therapy for carbohydrate metabolism disorders
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191049 Oligomers of nonpeptide restricted mimetics of dipeptides of tripeptides, and the use thereof in the synthesis of synthetic proteins and polypeptides
10/09/2003US20030190680 Photocleavable bioreactive agents
10/09/2003US20030190348 Cationic amphiphiles for intracellular delivery of therapeutic molecules and its composition, process and method of treatment
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003US20030189191 Fluorescent maleimides and uses thereof
10/09/2003CA2479928A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/08/2003EP1350790A1 Process for preparing active esters
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1446796A Process for preparing 2-phenil-3-naphthyl metacetonic acid derivative
10/07/2003US6630599 Process for preparing derivatives of isopropenyl-α, α-dimethylbenzyl isocyanate
10/07/2003US6630595 Using solid acid catalyst, reacting maleic anhydride and a primary amine in organic solvent; reusable catalyst, reduced waste disposal and lower costs
10/07/2003US6630505 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/07/2003US6630504 Phenoxyphenylheterocyclyl derivatives as SSRIs
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/02/2003WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof
10/02/2003WO2003080577A2 Amidoacetonitrile compounds
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003WO2003080060A1 Substituted piperazine antithrombotic pai-1 inhibitors
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003079975A2 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
10/02/2003WO2003064385A3 Delta1-pyrrolines and their use as pest control agents
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003US20030187278 Process for the synthesis of dipyrromethanes
10/02/2003US20030187057 Gabusectin derivatives, processes for preparing them and their use
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030186982 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
10/02/2003US20030186963 Central nervous system disorders; cardiovascular disorders
10/02/2003US20030186961 Central nervous system disorders; vision defects
10/02/2003US20030185864 Preventives or remedies for atopic dermatitis
10/02/2003CA2479881A1 Hif hydroxylase inhibitors
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/01/2003EP1348696A1 Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use
10/01/2003EP1348695A1 Derivatives of paraphenylene diamine with pyrrolidine groups substituted by cationic radicals and their use for dyeing keratinic fibre
10/01/2003EP1348692A1 Process for the preparation of amine oxides
10/01/2003EP1347989A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347958A1 Process for preparing distamycin derivatives
10/01/2003EP1347957A1 Delta 1-pyrrolines used as pesticides
10/01/2003EP1347956A1 Cyclizing method for synthesis of compounds derived from pyrrolidine
10/01/2003EP1347955A1 New mandelic acid derivatives and their use as throbin inhibitors
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003CN1446200A Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
10/01/2003CN1446199A New amidino derivatives and their use as thrombin inhibitors
10/01/2003CN1445615A Electric photographic organic photoreceptor with new charge transfer matter
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
09/2003
09/30/2003US6627769 Antiproliferative agents
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627760 Amorphous compound
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
09/25/2003WO2003080572A1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate
09/25/2003WO2003079339A1 Squarylium dyes as a light-absorbing compound in the information layer of optical data carriers
1 ... 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 ... 404